MIRA INFORM REPORT

 

 

Report No. :

318686

Report Date :

23.04.2015

 

IDENTIFICATION DETAILS

 

Name :

BISTOS CO., LTD.

 

 

Registered Office :

302, Galmachi-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, 7th Fl., A-dong, Seongnam Woolim Lion`s Valley 5-cha, Korea - 462-739

 

 

Country :

South Korea

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

27.08.2001

 

 

Com. Reg. No.:

120-86-25954

 

 

Legal Form :

Co., Ltd by Shares

 

 

Line of Business :

Manufacture of Other Medical and Surgical Equipment and Orthopedic Appliances n.e.c.

 

 

No. of Employees :

37

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

South Korea

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 


 

SOUTH KOREA - ECONOMIC OVERVIEW

 

South Korea over the past four decades has demonstrated incredible economic growth and global integration to become a high-tech industrialized economy. In the 1960s, GDP per capita was comparable with levels in the poorer countries of Africa and Asia. In 2004, South Korea joined the trillion-dollar club of world economies, and is currently the world's 12th largest economy. A system of close government and business ties, including directed credit and import restrictions, initially made this success possible. The government promoted the import of raw materials and technology at the expense of consumer goods, and encouraged savings and investment over consumption. The Asian financial crisis of 1997-98 exposed longstanding weaknesses in South Korea's development model, including high debt/equity ratios and massive short-term foreign borrowing. GDP plunged by 7% in 1998, and then recovered by 9% in 1999-2000. South Korea adopted numerous economic reforms following the crisis, including greater openness to foreign investment and imports. Growth moderated to about 4% annually between 2003 and 2007. South Korea's export focused economy was hit hard by the 2008 global economic downturn, but quickly rebounded in subsequent years, reaching over 6% growth in 2010. The US-Korea Free Trade Agreement was ratified by both governments in 2011 and went into effect in March 2012. Between 2012 and 2014, the economy experienced sluggish growth because of external market slowdowns. The administration in 2015 is likely to face the challenge of balancing heavy reliance on exports with developing domestic-oriented sectors, such as services. The South Korean economy's long-term challenges include a rapidly aging population, inflexible labor market, dominance of large conglomerates (chaebols), and the heavy reliance on exports, which comprise about half of GDP.

 

 

Source : CIA

 

Basic Information

 

Company Name

BISTOS CO., LTD.

Registered Address

302, Galmachi-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea

Building

7th Fl., A-dong, Seongnam Woolim Lion`s Valley 5-cha

Zip Code

462-739

Tel

+82-31-750-0340

Fax

+82-31-750-0344

E-mail

bistos@bistos.co.kr

Website

www.bistos.co.kr

Trading Address

7th Fl., A-dong, Seongnam Woolim Lion`s Valley 5-cha, 302, Galmachi-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea

(Old Address System : 7th Fl., A-dong, Seongnam Woolim Lion`s Valley 5-cha, 144-3, Sangdaewon 1-dong, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea)

Tel

+82-31-750-0340

Fax

+82-31-750-0344

Other Address

 

Tel

 

Fax

 

Type

Export

Industry

Manufacture of Other Medical and Surgical Equipment and Orthopedic Appliances n.e.c.

  Main Business

Fetal Doppler, Fetal Monitor

  Sub Business

 

Established (mm/dd/yyyy)

08/27/2001

 

 

Detailed Products

 

Activity

Detailed Products (UNSPSC)

Sell

Fetal or gynecological ultrasound or echo units(42201702)

Buy

Electrical wire(26121500)

Buy

Liquid crystal display LCD panels or monitors(43211902)

Buy

Rubber and elastomers(13100000)

Buy

Electrical receptacles(39121406)

Buy

Light emitting diodes LEDs(32111503)

Buy

Power supply units(39121004)

Buy

Bare printed circuit boards(32131010)

Buy

Direct current DC motors(26101603)

 

 

CEO’s

 

Name

Lee Hoo-Jeong

Address

Suite 108-102, 119, Hyeonchung-ro, Dongjak-gu, Seoul, Korea

Date of Birth

09/24/1963

Title

Representative Director

Sex

Male

Nationality

Korean

 

 

Profiles

 

Capital (KRW)

310,000,000

Employees

37

Formation

Co., Ltd by Shares

Bank Details

Nonghyup Bank

Corporate Registered No.

110111-2317653

Business Registered No.

120-86-25954

Permit & Licenses

09/17/2009 ISO 9001

04/20/2009 CE Mark

08/16/2007 CE Mark

08/12/2004 ISO 9001

07/29/2002 ISO 9001

 

Int’l Trade No.: 11994725

Shareholder Position

Name

Shares

%

LEE HOO-JEONG

28,706

46.30

HONG SUNG-SOO

15,500

25.00

LEE SOON-JA

4,030

6.50

KIM CHANG-JIN

1,984

3.20

KIM JAE-WOOK

1,178

1.90

PARK JUNG-HO

992

1.60

LEE JUNG-TAIK

992

1.60

OTHERS

8,618

13.90

TOTAL

62,000

100.00

Company History

08/27/2001 Incorporated as the present name

05/06/2008 Designated as an INNO-BIZ Company

10/28/2009 Designated as a Venture Business

11/04/2013 Designated as a Venture Business again

12/2013 Acquired BISTOS HEALTHCARE CO., LTD.

 

 

 

 

Detailed Information

 

Management

 

Job Description

Title

Name

Sex

Nationality

Inauguration Date

Representative Director

Mr.

Lee Hoo-Jeong

Male

Korean

08/27/2004

 

 

Financials

 

Year / Unit : KRW

Sales

Assets

Net Income

2014

 

 

 

2013

7,887,913,000

5,932,728,000

217,858,000

2012

6,025,830,000

5,957,090,000

431,113,000

2011

5,246,005,000

4,847,920,000

632,440,000

2010

4,222,838,000

2,470,531,000

580,793,000

2009

3,954,803,000

1,916,177,000

571,576,000

The latest financials are not available, and the Subject Company does not have any obligations to release its financials to the public.

 

 

Financial Description

 

Authorized Capital(KRW)

5,000,000,000

Paid-Up Capital(KRW)

310,000,000

Total Issued Shares

62,000

 

Balance Sheet

Unit : Korean Won

As of 12/31/2013

As of 12/31/2012

As of 12/31/2011

Total Assets

5,932,728,000

5,957,090,000

4,847,920,000

Current Assets

3,276,919,000

3,124,809,000

2,226,849,000

-Quick Assets

-

-

-

-Inventories

-

-

-

Fixed Assets

2,655,809,000

2,832,281,000

2,621,071,000

-Investment

-

-

-

-Tangibles

-

-

-

-Intangibles

-

-

-

Total Liabilities

3,053,311,000

3,214,532,000

2,474,475,000

Current Liabilities

721,783,000

862,944,000

455,836,000

Fixed Liabilities

2,331,528,000

2,351,588,000

2,018,639,000

Capital Stock

310,000,000

360,000,000

360,000,000

Capital Surplus

-

-

-

Profit Surplus

2,569,417,000

2,382,558,000

2,013,445,000

Capital Adjustment

-

-

-

Total Equity

-

-

-

Liab. & Shareholder’s Equity

2,879,417,000

2,742,558,000

2,373,445,000

 

Income Statement

Unit : Korean Won

As of 12/31/2013

As of 12/31/2012

As of 12/31/2011

Sales

7,887,913,000

6,025,830,000

5,246,005,000

Cost of Sold Goods

4,429,908,000

2,737,036,000

2,397,978,000

Gross Profit

3,458,005,000

3,288,794,000

2,848,027,000

Selling & Admin. Expenses

3,373,186,000

3,092,643,000

2,749,873,000

Operating Income

84,819,000

196,151,000

98,154,000

Non-Operating Income

336,076,000

410,634,000

658,138,000

Non-Operating Expenses

203,037,000

174,165,000

122,870,000

Income Before Taxes

217,858,000

432,620,000

633,422,000

Income Taxes Expenses

-

1,507,000

982,000

Net Income

217,858,000

431,113,000

632,440,000

 

Cash Flows

Unit : Korean Won

As of 12/31/2013

As of 12/31/2012

As of 12/31/2011

Cash Flows from Operating

 

 

 

-Net Income

 

 

 

-Exp. without Cash Outflow

 

 

 

-Revenue without Cash Inflows

 

 

 

-Changes in Asset/ & Liability

 

 

 

Cash Flows from Investing

 

 

 

-Cash Inflow from Investing

 

 

 

-Cash Outflows for Investing

 

 

 

Cash Flows from Financing

 

 

 

-Cash Inflows from Financing

 

 

 

-Cash Outflows from Financing

 

 

 

Increase/Decrease in Cash

 

 

 

Cash at the Beginning of Year

 

 

 

Cash at the End of Year

 

 

 

 

 

Products, Technologies, Services Description

 

Main Products & Services

Fetal Doppler, Fetal Monitor

Detailed Products Spec.

 

Technologies Acquired

 

 

 

Trade Partners & Competitors

 

Suppliers

 

Customers

 

Competitors

M.I.TECH CO., LTD.

241-3, HABUK-RI, JINWI-MYEON, PYEONGTAEK-SI, GYEONGGI-DO, KOREA

TEL:+82-31-662-5645  FAX:+82-31-662-5648

 

HANMI MEDITECH INC.

RM. 122, MEDICAL EQUIPMENT INDUSTRIAL COMPLEX, 1720-26, TAEJANG-DONG, WONJU-SI, GANGWON-DO, KOREA

TEL:+82-33-734-1811  FAX:+82-33-734-1812

 

E-WHA BIOMEDICS CO., LTD.

1-4, MYEONGNYUNDONG 1-GA, JONGNO-GU, SEOUL, KOREA

TEL:+82-2-2055-3820  FAX:+82-2-2055-3819

 


Sales by Region (Activity & Markets)

 

The Subject exports to Germany, Mexico, USA, Japan, China and Thailand.

 

 

Court Action

 

Not Available.

 

 

News Clipping

 

--


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.82

UK Pound

1

Rs.93.85

Euro

1

Rs.67.57

 

INFORMATION DETAILS

 

Analysis Done by :

KAR

 

 

Report Prepared by :

VNT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.